Sanofi's Chew on Auvi-Q Voice-Guided Injector

Sanofi's Chew on Auvi-Q Voice-Guided Injector Play

Aug. 15 (Bloomberg) -- Paul Chew, chief science officer for Sanofi Aventis USA, talks about the company's Auvi-Q injection system for the emergency treatment of life-threatening allergic reactions. Auvi-Q is the first and only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers through the injection process. Chew speaks with Dominic Chu on Bloomberg Television's "Bottom Line." Mark Crumpton also speaks. (Source: Bloomberg)

  • On Air Now

    Bloomberg West Watch Now

  • Next

    Bloomberg Bottom Line

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus